Ceraxon ® is a pharmaceutical preparation of CDP-choline (Citicoline), a choline-containing phospholipid. It is one of the most efficient supplemental forms of choline along with Alpha-GPC (Cereton).Deficiency of choline may lead to fatty liver disease, atherosclerosis, and various neurological disorders. The use of some nootropic drugs such as Piracetam and Noopept might also require an additional choline supplementation.Indications for use
Citicoline works by increasing the synthesis of phosphatidylcholine (the primary component of neuronal cell membranes) and acetylcholine - a major neurotransmitter involved in cognitive functioning.
Dosage and administration
Ceraxon should be administered during or between meals. Before administering, you should dissolve the content of one sachet in a ½ cup of water. The dosage in the acute stage of ischemic stroke and traumatic brain injury is 1000mg (10ml or one sachet) every 12 hours. The length of the treatment course should be not less than six weeks.
The dose is 500-2000mg/day (5-10ml 1-2 times a day, or one sachet 1-2 times a day) for rehabilitation after stroke/TBI and the treatment of cognitive disorders caused by degenerative and vascular diseases. The length of the treatment depends on the patient’s condition. The dose for elderly patients is the same.
The drug is generally well-tolerated, although some patients still may experience the following side effects:
Citicoline may potentiate the effect of L-Dopa. Ceraxon should not be administered in conjunction with meclofenoxate (centrophenoxine).